Systems immunology reveals the molecular mechanisms of heterogeneous influenza vaccine response in the elderly

Vaccination-induced protection against influenza is greatly diminished and increasingly heterogeneous with age. We investigated longitudinally (up to five timepoints) a cohort of 234 elderly influenza vaccinees across two independent seasons including up to six modalities (multi-omics and immunological parameters). System-level analyses revealed responders exhibited time-dependent changes attributed to a productive vaccine response across all omics layers whereas non-responders did not follow such dynamics, suggestive of systemic dysregulation. Through multi-omics integration, we identified key metabolites and proteins and their likely role in immune response to vaccination. High pre-vaccination IL-15 concentrations negatively associated with antibody production, further supported by experimental validation in mice revealing an IL-15-driven NK-cell axis with a suppressing role on antibody production. Finally, we propose certain long-chain fatty acids as modulators of persistent inflammation in non-responders. Our findings highlight the potential for stratification of vaccinees and open avenues for possible pharmacological interventions to enhance vaccine responses.

[1]  M. Davenport,et al.  Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities , 2023, Nature Immunology.

[2]  R. Ribeiro,et al.  Illuminating a blind spot in SARS-CoV-2 immunity , 2023, Nature Immunology.

[3]  M. Akmatov,et al.  Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly , 2022, Nature Communications.

[4]  B. Pulendran,et al.  Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination , 2022, Nature immunology.

[5]  Wenkai Luo,et al.  Influenza vaccination features revealed by a single‐cell transcriptome atlas , 2022, Journal of medical virology.

[6]  M. Caligiuri,et al.  Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy. , 2022, Trends in immunology.

[7]  Samit R. Joshi,et al.  Metabolomic and transcriptomic signatures of influenza vaccine response in healthy young and older adults , 2022, Aging cell.

[8]  T. Illig,et al.  Reprogramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Exacerbation of Chronic Obstructive Pulmonary Disease , 2022, Cells.

[9]  Stephanie K Venn-Watson,et al.  Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems , 2022, PloS one.

[10]  M. Ferrero,et al.  The Dual Role of CCR5 in the Course of Influenza Infection: Exploring Treatment Opportunities , 2022, Frontiers in Immunology.

[11]  M. Netea,et al.  Induction of trained immunity by influenza vaccination - impact on COVID-19 , 2021, medRxiv.

[12]  Zhi Yang,et al.  The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases , 2021, Frontiers in Cell and Developmental Biology.

[13]  S. Waggoner,et al.  Targeting natural killer cells to enhance vaccine responses. , 2021, Trends in pharmacological sciences.

[14]  R. Xavier,et al.  Integration of metabolomics, genomics, and immune phenotypes reveals the causal roles of metabolites in disease , 2021, Genome biology.

[15]  Mark M. Davis,et al.  The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination , 2021, Cell.

[16]  M. Battaglia,et al.  Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study , 2021, Scientific Reports.

[17]  M. Thompson,et al.  Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. , 2021, Vaccine.

[18]  Xiao-ning Xu,et al.  Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly , 2020, Frontiers in Immunology.

[19]  A. Díaz,et al.  B Cell Immunosenescence. , 2020, Annual review of cell and developmental biology.

[20]  S. Paust,et al.  Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection , 2020, Frontiers in Cellular and Infection Microbiology.

[21]  B. Kelly,et al.  Amino Assets: How Amino Acids Support Immunity. , 2020, Cell metabolism.

[22]  F. Klawonn,et al.  Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells , 2020, Vaccines.

[23]  E. Dennis,et al.  Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? , 2020, Scientific Reports.

[24]  S. Pazzaglia,et al.  Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases , 2019, Cells.

[25]  Zhendong Niu,et al.  PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-κB activity. , 2019, Life sciences.

[26]  E. Riley,et al.  Natural Killer Cells Dampen the Pathogenic Features of Recall Responses to Influenza Infection , 2019, bioRxiv.

[27]  B. Pulendran,et al.  Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans , 2019, Cell.

[28]  A. Shaw,et al.  Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults , 2019, The Journal of Immunology.

[29]  M. Akmatov,et al.  Self-reported diabetes and herpes zoster are associated with a weak humoral response to the seasonal influenza A H1N1 vaccine antigen among the elderly , 2019, BMC Infectious Diseases.

[30]  M. Gale,et al.  Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus , 2019, Nature Immunology.

[31]  Xiaopei Huang,et al.  PARP-1 controls NK cell recruitment to the site of viral infection. , 2019, JCI insight.

[32]  F. Koch-Nolte,et al.  Purine Release, Metabolism, and Signaling in the Inflammatory Response. , 2019, Annual review of immunology.

[33]  Yulong Yin,et al.  Betaine Inhibits Interleukin-1β Production and Release: Potential Mechanisms , 2018, Front. Immunol..

[34]  Julian Q. Zhou,et al.  Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers , 2018, Cell reports.

[35]  Raj C. Shah,et al.  Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5. , 2018, Clinical immunology.

[36]  Martin Jaeger,et al.  Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses , 2018, Nature Immunology.

[37]  J. Marioni,et al.  Multi‐Omics Factor Analysis—a framework for unsupervised integration of multi‐omics data sets , 2018, Molecular systems biology.

[38]  Zeyang Zhou,et al.  Serpin functions in host-pathogen interactions , 2018, PeerJ.

[39]  S. Tangye,et al.  Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity , 2018, Science Translational Medicine.

[40]  D. Gudbjartsson,et al.  Age and Influenza-Specific Pre-Vaccination Antibodies Strongly Affect Influenza Vaccine Responses in the Icelandic Population whereas Disease and Medication Have Small Effects , 2018, Front. Immunol..

[41]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[42]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[43]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[44]  J. Sampson,et al.  Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3 , 2017, Expert review of clinical immunology.

[45]  M. Akmatov,et al.  Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population , 2017, Human vaccines & immunotherapeutics.

[46]  Rob Patro,et al.  Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.

[47]  M. Akmatov,et al.  Motivations for (non)participation in population-based health studies among the elderly – comparison of participants and nonparticipants of a prospective study on influenza vaccination , 2017, BMC Medical Research Methodology.

[48]  R. Xavier,et al.  A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans , 2016, Cell.

[49]  R. Xavier,et al.  Differential Effects of Environmental and Genetic Factors on T and B Cell Immune Traits , 2016, Cell reports.

[50]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.

[51]  A. Boonstra,et al.  IFN‐λ is able to augment TLR‐mediated activation and subsequent function of primary human B cells , 2015, Journal of leukocyte biology.

[52]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[53]  R. Welsh,et al.  Generation of cellular immune memory and B-cell immunity are impaired by natural killer cells , 2015, Nature Communications.

[54]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[55]  M. Idzko,et al.  Nucleotide signalling during inflammation , 2014, Nature.

[56]  Ruth R. Montgomery,et al.  Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling. , 2014, Clinical immunology.

[57]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[58]  A. Chawla,et al.  Metabolic regulation of immune responses. , 2014, Annual review of immunology.

[59]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[60]  K. Coombs,et al.  Knockdown of specific host factors protects against influenza virus-induced cell death , 2013, Cell Death and Disease.

[61]  C. Weyand,et al.  Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.

[62]  D. Weiner,et al.  Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant , 2012, Human vaccines & immunotherapeutics.

[63]  D. Rose,et al.  IL-15 Participates in the Respiratory Innate Immune Response to Influenza Virus Infection , 2012, PloS one.

[64]  P. Lang,et al.  Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence , 2012, Clinical interventions in aging.

[65]  Timothy M. D. Ebbels,et al.  Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA , 2011 .

[66]  Nicola Zamboni,et al.  High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. , 2011, Analytical chemistry.

[67]  Eva K. Lee,et al.  Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.

[68]  N. Maeda,et al.  Interleukin-15 Is Critical in the Pathogenesis of Influenza A Virus-Induced Acute Lung Injury , 2010, Journal of Virology.

[69]  J. D. Di Santo,et al.  IL-15 trans-presentation promotes human NK cell development and differentiation in vivo , 2009, The Journal of experimental medicine.

[70]  A. Reed.  Faculty Opinions recommendation of TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. , 2007 .

[71]  R. Bram,et al.  TACI Is Required for Efficient Plasma Cell Differentiation in Response to T-Independent Type 2 Antigens1 , 2007, The Journal of Immunology.

[72]  E. Ferriolli,et al.  Effects of arginine supplementation on the humoral and innate immune response of older people , 2005, European Journal of Clinical Nutrition.

[73]  D. Girard,et al.  Interleukin‐15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl‐1 and decreased activity of caspase‐3 and caspase‐8 , 2004, Journal of leukocyte biology.

[74]  A. Moretta.  Natural killer cells and dendritic cells: rendezvous in abused tissues , 2002, Nature Reviews Immunology.

[75]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[76]  A. Barbul,et al.  Arginine stimulates lymphocyte immune response in healthy human beings. , 1981, Surgery.

[77]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .